Pharvaris
Develops oral therapies for people with hereditary and other bradykinin-mediated angioedema
Highlights
- New on EvolcAdded 2026-11-14
About Pharvaris
Pharvaris develops investigational oral bradykinin B2 receptor antagonists for bradykinin-mediated angioedema, including hereditary angioedema and acquired angioedema due to C1 inhibitor deficiency.
The company is headquartered in Zug, Switzerland, with offices in Leiden, the Netherlands, and Lexington, Massachusetts. It was founded in 2015 and is a late-stage, Nasdaq-listed biopharmaceutical company.
Product: Investigational oral bradykinin B2 receptor antagonist therapies for bradykinin-mediated angioedema.
Jobs at Pharvaris
More biotech & pharma companies
Phathom Pharmaceuticals
Develops and commercializes prescription treatments for patients with acid-related gastrointestinal disordersNew on EvolcPlasmidsaurus
DNA sequencing services and bioinformatics tools for scientists and biology researchersRemote-friendlySalary transparentPraxis Precision Medicines
Develops precision neuroscience medicines for people with epilepsy, movement disorders and other CNS conditionsNew on EvolcPtcbio
Biopharmaceutical company developing and commercializing medicines for children and adults with serious rare diseasesNew on EvolcRemote-friendlyRecursion
AI-enabled drug discovery and development for pharmaceutical partners and patients with oncology and rare diseasesRemote-friendlySalary transparentRemix Therapeutics
Clinical-stage biotech developing small-molecule mRNA degraders for solid tumors and blood cancersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
- Cookie namedistinctive cookie name
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- BambooHRMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.